# ClinicalTrials.gov record NCT06987513

> PeptideScanner retained ClinicalTrials.gov record NCT06987513 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was pemvidutide.

- Evidence object: `story:clinicaltrials-gov-nct06987513-pemvidutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-31
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06987513-pemvidutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06987513-pemvidutide-v1.json
- Content SHA-256: `f229089f90e32f8de96dadaf12887917fe13ab5d7ca58e8b037760af9ebfef7a`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06987513 ([`ctg-observation-nct06987513-2026-07-31-1e0339600b69`](#source-ctg-observation-nct06987513-2026-07-31-1e0339600b69))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06987513 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was pemvidutide. ([`ctg-observation-nct06987513-2026-07-31-1e0339600b69`](#source-ctg-observation-nct06987513-2026-07-31-1e0339600b69))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06987513 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was pemvidutide. ([`ctg-observation-nct06987513-2026-07-31-1e0339600b69`](#source-ctg-observation-nct06987513-2026-07-31-1e0339600b69))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06987513-2026-07-31-1e0339600b69`](#source-ctg-observation-nct06987513-2026-07-31-1e0339600b69))

## Sources

<a id="source-ctg-observation-nct06987513-2026-07-31-1e0339600b69"></a>
- **ClinicalTrials.gov record NCT06987513 · retained source version 2026-07-31:1e0339600b69d593251060e3e950a1115e96aaa4c5a8b3ff662651ac4049cd93** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06987513) (`ctg-observation-nct06987513-2026-07-31-1e0339600b69`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06987513." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06987513-pemvidutide-v1.json SHA-256: f229089f90e32f8de96dadaf12887917fe13ab5d7ca58e8b037760af9ebfef7a.